封面
市场调查报告书
商品编码
1864337

按剂型、作物类型、应用方法、最终用户和销售管道的Buprofezin市场—2025-2032年全球预测

Buprofezin Market by Formulation Type, Crop Type, Application Method, End User, Sales Channel - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年,Buprofezin市场规模将成长至 11.6547 亿美元,复合年增长率为 5.44%。

关键市场统计数据
基准年 2024 7.6259亿美元
预计年份:2025年 8.0381亿美元
预测年份 2032 11.6547亿美元
复合年增长率 (%) 5.44%

对Buprofezin进行了权威的介绍,涵盖了其作为昆虫生长调节剂的作用机制、在主要作物中的应用以及监管和管理背景。

在现代综合虫害管理(IPM)模式中,Buprofezin作为一种昆虫生长调节剂,具有独特的地位。它能抑制主要吸汁害虫的蜕皮和发育。农民依靠其定向的作用机制来控制威胁棉花、水稻、蔬菜和某些水果作物的粉蝨、介壳虫、叶蝉和其他半翅目害虫的数量。由于噻Buprofezin酮作用于幼虫阶段而非直接击倒,因此在抗药性缓解和残留控制等因素影响战术性策略时,可以有效地与其他化学和生物製剂合併使用。

监管审查和负责任的管理措施正日益影响配方师和施药人员使用Buprofezin的方式。因此,配方师致力于开发能够优化作物安全性、方便操作人员使用并最大限度减少非目标生物暴露的给药形式。同时,种植者和顾问也在调整施药时间和混合策略,以确保产品在害虫世代更迭中保持有效性。随着我们从单季病虫害管理方案转向全季病虫害管理方案,相关人员越来越重视作物轮作、监测以及与益虫族群的共存。

综合以上趋势,目前关于Buprofezin的争论可以概括如下:虽然噻嗪酮是控制特定害虫群落的有效策略,但其长期效用取决于协调管理、配方创新以及与不断变化的监管要求保持一致。这些因素正在切实地影响采购决策、宣传通讯和产品开发蓝图。

变革性的技术、监管和分销变化将重新定义Buprofezin产品的配方、监管和在作物系统中的部署方式。

Buprofezin的市场格局正在发生变化,多种趋势正在改变农作物保护产品的研发、行销和使用方式。精密农业和数位化决策支援工具正在革新施药时间和剂量选择,使种植者能够根据即时病虫害监测结果,将Buprofezin整合到精准防治策略中。同时,製剂科学也在不断发展,以提高混配相容性、附着力、耐雨性和作物安全性,进而影响不同种植系统中噻嗪酮类杀虫剂的应用。

更严格的监管以及对环境和工人安全的日益严格审查,正在加速对健全的管理方案和透明资料包的需求。因此,生产商和註册人越来越重视残留物表征、非目标风险评估和标籤说明。供应链格局也在发生变化,全球采购和原料供应迫使配方商重新评估製造地并重新审视合约伙伴关係。此外,分销行为的转变——包括与农民直接互动的增加和线上采购管道的成长——正在改变技术支援和培训的提供方式。

这些因素相互作用:配方技术的创新和数据驱动的应用技术有助于提高合规性和疗效,而不断演变的经销和供应模式正在改变资讯和产品到达最终用户的方式。能够预见并应对这些变化的相关人员可以提高营运效率,从而保持疗效、减少监管摩擦并增强产品的长期生存能力。

受2025年关税环境影响,供应链、采购和分销环节将发生变化,导致Buprofezin製剂和原料的取得途径受到影响。

美国2025年实施的关税和贸易措施对依赖全球供应链获取活性成分、惰性成分和製剂服务的产品(例如Buprofezin)产生了连锁的间接影响。某些前驱化学品和包装材料的进口成本上升,推高了国际製剂生产商的单位成本,迫使采购团队重新评估其供应商组合,并优先考虑在地采购和多元化。为此,一些生产商调整了生产顺序和库存管理策略,以降低关税波动带来的风险,并在关键种植期保持供应的连续性。

在分销和终端用户层面,成本转嫁动态因通路和客户类型而异。拥有整合采购结构和长期采购合约的大型农业经营者比依赖现货采购且营运资金更为紧张的小型农场更能承受短期投入价格波动。此外,关税引发的变化促使贸易流量重组,一些供应商寻求替代出口目的地,并加快在受关税影响市场的国内註册和生产计画。

重点,政策环境促进了註册人、合规专业人员和销售团队之间的密切合作,以确保贴标产品的持续供应,同时遵守监管义务。总体而言,2025 年关税趋势更加强调供应链韧性、供应来源多元化以及保护生产商和配方商免受暂时性贸易中断影响的合约策略。

详细的細項分析揭示了製剂选择、作物类别、施用方法、最终用户画像和销售管道如何共同影响Buprofezin的采用决策。

关键细分维度的洞察揭示了Buprofezin产品的差异化需求驱动因素、施用方法偏好和商业化策略。根据製剂类型,相关人员会评估浓缩液、颗粒剂、浓缩液和可湿性粉剂在特定施用时间、作物安全性以及操作人员操作要求方面的适用性。在需要快速混合和界面活性剂相容性的场合,浓缩液往往是首选;而颗粒剂则可透过土壤或水进行靶向施用,适用于水稻和撒播。在药效依赖叶面接触和在复杂冠层中均匀覆盖的情况下,悬浮剂和可湿性粉剂仍然具有价值。

目录

第一章:序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 温室蔬菜中越来越多采用Buprofezin製剂防治粉蝨
  • 在永续作物保护计画中扩大经有机认证的Buprofezin酮类生物防治剂的使用规模
  • 将无人机精准喷洒技术应用于大规模棉花种植中的Buprofezin防治
  • 亚太市场对Buprofezin在水稻种植的应用监管核准不断增加
  • 开发奈米封装的Buprofezin净递送系统以提高其在野外的稳定性和疗效
  • 农药生产商之间关于Buprofezin专利联盟和共同开发的策略联盟
  • 原物料成本上涨对主要生产商Buprofezin生产利润率的影响
  • 综合虫害管理 (IPM) 的日益普及推动了 IPM 计画中Buprofezin的使用量增加。

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章 以剂型分類的Buprofezin市场

  • 乳化浓缩液
  • 颗粒
  • 暂停
  • 可湿性粉

第九章 依作物类型分類的Buprofezin市场

  • 棉布
  • 果树
    • 莓果
    • 柑橘
    • 核果
  • 蔬菜
    • 水果和蔬菜
    • 绿叶蔬菜
    • 根茎类

第十章 依应用方法分類的Buprofezin市场

  • 叶面喷布
  • 种子处理
  • 土壤处理

第十一章Buprofezin市场:依最终用户划分

  • 大型农场
  • 小农场

第十二章Buprofezin市场销售管道

  • 直销
  • 批发商
  • 在线的

第十三章Buprofezin市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章Buprofezin市场:依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国Buprofezin市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵,2024
  • 竞争分析
    • Sumitomo Chemical Co., Ltd.
    • Nippon Soda Co., Ltd.
    • Jiangsu Changqing Agrochemical Co., Ltd.
    • Adama Agricultural Solutions Ltd.
    • UPL Limited
    • Dhanuka Agritech Limited
    • Nufarm Limited
    • Jiangsu Huifeng Agrochemical Co., Ltd.
    • Shandong United Pesticide Industry Co., Ltd.
    • Gharda Chemicals Limited
Product Code: MRR-2B4B2861EC8B

The Buprofezin Market is projected to grow by USD 1,165.47 million at a CAGR of 5.44% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 762.59 million
Estimated Year [2025] USD 803.81 million
Forecast Year [2032] USD 1,165.47 million
CAGR (%) 5.44%

An authoritative introduction to buprofezin covering its insect growth regulator mode of action, primary crop applications, regulatory and stewardship context

Buprofezin occupies a distinct position within contemporary integrated pest management frameworks as an insect growth regulator that disrupts molting and development in key sap-sucking pests. Agricultural practitioners rely on its targeted mode of action to manage populations of whiteflies, scale insects, planthoppers, and other hemipteran pests that threaten cotton, rice, vegetables, and certain fruit categories. Because it affects immature stages rather than providing acute knockdown, buprofezin integrates effectively with complementary chemistries and biological agents when resistance mitigation and residue considerations shape tactical decisions.

Regulatory scrutiny and stewardship commitments increasingly influence the way formulators and applicators deploy buprofezin. Consequently, formulators have invested in delivery formats that optimize crop safety and operator handling while minimizing non-target exposure. In parallel, growers and advisors have adapted application timing and tank-mix strategies to preserve product efficacy across successive pest generations. Transitioning from single-season interventions toward season-long pest management programs, stakeholders emphasize rotation, monitoring, and compatibility with beneficial insect populations.

Taken together, these dynamics frame the current discourse around buprofezin: it is a strategic tool for controlling specific pest complexes, yet its long-term utility depends on coordinated stewardship, formulation innovation, and alignment with evolving regulatory expectations. Those factors shape procurement decisions, extension messaging, and product development roadmaps in practical ways.

Transformative technological, regulatory, and distributional shifts that are redefining how buprofezin products are formulated, regulated, and deployed across crop systems

The landscape for buprofezin is shifting as several transformative trends converge to reshape how crop protection products are developed, marketed, and used. Precision agriculture and digital decision-support tools have changed application timing and dosage selection, enabling growers to integrate buprofezin into targeted interventions informed by real-time pest monitoring. At the same time, formulation science has evolved to address compatibility with tank-mix partners and to improve adherence, rainfastness, and crop safety, which in turn influences product uptake across diverse cropping systems.

Regulatory tightening and heightened scrutiny on environmental and operator safety have accelerated demand for robust stewardship programs and transparent data packages. Consequently, manufacturers and registrants place greater emphasis on residue characterization, non-target risk assessments, and label clarity. Supply chain dynamics have also changed, as global sourcing and raw material availability prompt formulators to re-evaluate manufacturing footprints and contract partnerships. In addition, shifts in distribution behavior - including expanding direct-to-grower engagement and the growth of online procurement channels - are altering how technical support and training are delivered.

These forces operate together: innovation in formulation and data-driven application practices supports compliance and efficacy, while evolving distribution and supply arrangements change how information and product reach end users. Stakeholders who anticipate and respond to these shifts can protect efficacy, reduce regulatory friction, and capture operational efficiencies that strengthen long-term product viability.

How the 2025 tariff environment produced cascading supply chain, procurement, and distribution effects that reshaped access to buprofezin formulations and inputs

The implementation of tariffs and trade measures by the United States in 2025 created a cascade of indirect effects for products like buprofezin that rely on global supply chains for active ingredients, inert components, and formulation services. Increased import costs for certain precursor chemicals and packaging materials raised the unit cost base for formulators who sourced components internationally, prompting procurement teams to reevaluate supplier portfolios and to prioritize localized or diversified supply relationships. In turn, some manufacturers adjusted production sequencing and inventory policies to mitigate exposure to tariff volatility and to preserve continuity of supply for key cropping periods.

At the distribution and end-user level, cost pass-through dynamics varied by channel and customer type. Large agricultural operations with integrated purchasing and longer-term procurement contracts absorbed short-term input price movements more easily than small-scale farms that depend on spot purchases and may face tighter working capital constraints. Moreover, tariff-driven changes fostered reconfiguration in trade flows, encouraging some suppliers to seek alternative export destinations or to accelerate domestic registration and production plans in tariff-affected markets.

Importantly, the policy environment stimulated closer collaboration between registrants, compliance specialists, and commercial teams to ensure uninterrupted access to labeled products while remaining compliant with regulatory obligations. In sum, tariff developments in 2025 heightened focus on supply chain resilience, supplier diversification, and contractual strategies that buffer growers and formulators from episodic trade disruptions.

Granular segmentation insights revealing how formulation choices, crop categories, application methods, end-user profiles, and sales channels collectively shape buprofezin deployment decisions

Insights across key segmentation dimensions reveal differentiated demand drivers, application preferences, and commercialization strategies for buprofezin products. Based on formulation type, stakeholders evaluate emulsifiable concentrates, granules, suspension concentrates, and wettable powders for their fit with specific application windows, crop safety profiles, and operator handling requirements; emulsifiable concentrates often appeal where rapid mixing and compatibility with surfactants matter, while granule formats can offer targeted soil- or water-delivered options for paddy or broadcast applications. Suspension concentrates and wettable powders remain valuable where foliar contact and uniform coverage across complex canopies determine efficacy.

Based on crop type, users tailor selection to the pest complex and crop physiology. Cotton, fruit, paddy, and vegetables each present unique considerations: cotton programs prioritize control of sap-sucking pests across multiple growth stages; fruit applications require attention to preharvest intervals and pollinator exposure, with fruit categories further dissected across berry, citrus, and stone fruit for varying residue and canopy management needs; paddy systems often favor formulations and application windows synchronized with planthopper life cycles; vegetables require agile application timing across fruit vegetables, leafy vegetables, and root vegetables where harvest schedules and residue tolerances differ.

Based on application method, deployment choices cluster around foliar spray, seed treatment, and soil treatment options, with foliar spray remaining the prevalent mode for rapid suppression of active infestations and seed or soil treatments offering prophylactic protection in select systems. Based on end user, the distinction between large scale farms and small scale farms affects purchasing patterns, technical support needs, and willingness to adopt premium formulations or subscription-based supply models. Based on sales channel, direct sales, distributors, and online platforms each present trade-offs between hands-on technical service, reach into fragmented geographies, and convenience; distributors often provide localized agronomic support while direct sales can bundle technical training and stewardship commitments, and online channels increasingly serve smaller buyers seeking transactional convenience. Together, these segmentation lenses inform product development priorities, extension strategies, and channel investments in ways that reflect agronomic realities and commercial constraints.

Regional agronomic, regulatory, and distribution nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine product use and commercialization pathways

Regional dynamics shape how buprofezin is used, regulated, and commercialized across diverse cropping systems. In the Americas, adoption patterns reflect a mix of specialty crop and row crop needs; technical support and distributor networks play a central role in translating label constraints into field practice, and growers often seek integration with broader pest management tools suitable for cotton, vegetables, and fruit systems. Regulatory engagement and stewardship programs in this region emphasize worker safety and environmental risk mitigation, which influence formulation preferences and application timing.

In Europe, Middle East & Africa, regulatory frameworks and regional climatic diversity create heterogeneous demand and approval conditions. Some jurisdictions emphasize stringent residue and non-target species assessments that shape label language and permissible use patterns, while others prioritize access for key staple or export-oriented crops. Technical advisories and extension networks in these geographies frequently guide growers toward integrated approaches that balance efficacy with compliance and market access objectives.

In Asia-Pacific, agricultural systems characterized by intensive rice cultivation, extensive vegetable production, and significant smallholder presence rely heavily on targeted tools for planthopper and sap-sucking pest complexes. Here, formulations that suit paddy application regimes and mixed-cropping calendars gain traction, and stewardship messaging that accounts for multiple cropping cycles proves essential. Across regions, supply chain configuration, regulatory drivers, and agronomic practices interact to determine which channels, formulations, and advisory models best support effective and sustainable use.

Strategic company-level imperatives focusing on formulation innovation, regulatory stewardship, channel partnerships, and service integration to sustain competitive advantage

Competitive dynamics among manufacturers, formulators, and service providers center on formulation innovation, regulatory expertise, and channel reach. Leading enterprises prioritize investments in formulation platforms that enhance compatibility with precision application technologies and that reduce operator exposure while maintaining efficacy against target pest complexes. At the same time, contract manufacturing and private-label arrangements allow regional formulators to tailor products to local cropping systems and regulatory conditions, creating opportunities for agile market entrants.

R&D teams and regulatory affairs specialists collaborate to build robust data packages that support label renewal, risk mitigation, and stewardship initiatives. Partnerships between technical teams and commercial units increasingly aim to translate efficacy data into actionable extension materials and training programs for distributors and end users. Additionally, companies that offer integrated services - combining product supply with digital advisory tools, monitoring services, or custom formulations - differentiate on the basis of convenience and technical value.

Mergers, licensing arrangements, and distribution partnerships remain important mechanisms for scaling geographic reach and accelerating product registration timelines without duplicative capital investment. In this environment, firms that maintain strong relationships with growers, extension agents, and channel partners can more effectively deploy stewardship programs and respond to evolving regulatory expectations, thereby preserving product relevance over multiple cropping cycles.

Actionable recommendations for manufacturers and distributors to fortify supply resilience, advance stewardship, and optimize commercialization of buprofezin products

Industry leaders can take several practical steps to strengthen product resilience, protect efficacy, and expand responsible use of buprofezin. First, prioritize formulation development that improves ease of use, reduces operator exposure, and enhances compatibility with integrated pest management practices; investing in adjuvant science and delivery systems reduces barriers to adoption and can lengthen product lifecycle utility. Second, build robust stewardship and resistance management programs that combine clear label instructions, train-the-trainer initiatives for distributors and advisors, and monitoring protocols that inform rotation and tank-mix choices.

Third, diversify supply chains by securing multiple qualified suppliers for key inputs and by assessing local or regional manufacturing options to reduce exposure to trade volatility. Fourth, strengthen relationships with end users through bundled services that include agronomic advisory, digital decision-support tools, and field-level diagnostics; these offerings create recurring engagement and improve proper product use. Fifth, engage proactively with regulatory authorities and industry associations to streamline data submissions, address non-target risk considerations, and align residue management strategies with export market requirements.

Finally, tailor commercialization strategies to channel dynamics: support distributors with localized technical materials, develop direct-sales pilots for high-value customers, and design online offerings for smaller buyers who value convenience. By combining technical innovation with supply resilience and targeted commercial models, industry leaders can sustain product relevance while meeting evolving regulatory and grower expectations.

A transparent hybrid research methodology combining primary interviews, regulatory and technical literature review, and field validation to triangulate practical insights on buprofezin use

This research synthesizes insights from a hybrid methodology combining primary interviews, regulatory documentation review, technical literature synthesis, and field-level observation to ensure robust, triangulated findings. Primary qualitative interviews included crop protection specialists, formulation scientists, registrants' regulatory leads, distributors, and grower advisors to capture on-the-ground practices and strategic priorities. Complementary secondary analysis drew on peer-reviewed entomology and agronomy literature, publicly available regulatory filings, and company disclosures to contextualize efficacy profiles, residue management practices, and label constraints.

Field-level observation and practitioner feedback informed assessments of application timing, formulation performance under diverse climatic conditions, and stewardship practices at farm scale. Data triangulation helped reconcile differences between controlled-trial efficacy and practical in-field outcomes, while expert validation workshops reviewed preliminary conclusions to ensure relevance and clarity. Quality assurance measures included cross-referencing regulatory documents against reported use patterns and seeking clarifications from technical interviewees when discrepancies emerged.

Throughout the research process, ethical considerations and confidentiality requirements guided interactions with commercial participants. The methodology emphasizes transparency in source attribution and replicability of approach while acknowledging practical limitations inherent in rapidly evolving regulatory and trade contexts.

Concluding synthesis emphasizing the sustained agronomic role of buprofezin alongside the necessity for stewardship, supply resilience, and coordinated commercial strategies

In conclusion, buprofezin remains a targeted and valuable tool within integrated pest management programs for specific sap-sucking pest complexes across cotton, rice, vegetables, and select fruit crops. Its role is reinforced by formulation advancements and data-driven application practices, even as regulatory scrutiny and trade dynamics challenge supply continuity and cost structures. The combined pressures of stewardship expectations, changing distribution channels, and trade policy shifts necessitate adaptive approaches in procurement, product development, and grower engagement.

Stakeholders that align formulation innovation with robust stewardship, diversify supply relationships, and invest in channel-specific technical support will better sustain efficacy and retain grower confidence. Moreover, integrating digital advisory services and localized training into commercialization strategies strengthens correct use and reduces the risk of resistance development. As the sector evolves, decision-makers should prioritize operational resilience and proactive regulatory engagement to preserve both access and product integrity.

Taken together, these conclusions underscore the importance of coordinated action across R&D, regulatory, supply chain, and commercial functions to maintain the utility of buprofezin in modern crop protection portfolios while addressing environmental and market expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of buprofezin formulations for controlling whitefly infestations in greenhouse vegetables
  • 5.2. Expansion of organic-certified buprofezin-based bioinsecticides in sustainable crop protection programs
  • 5.3. Integration of drone-based precision application techniques for buprofezin in large-scale cotton farming
  • 5.4. Increasing regulatory approvals of buprofezin for use in paddy rice cultivation across Asia Pacific markets
  • 5.5. Development of nano-encapsulated buprofezin delivery systems to enhance field stability and efficacy
  • 5.6. Strategic collaborations between agrochemical companies for buprofezin patent pooling and co-development
  • 5.7. Impact of rising raw material costs on buprofezin production margins among key manufacturers
  • 5.8. Surge in integrated pest management adoption driving increased use of buprofezin in IPM programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Buprofezin Market, by Formulation Type

  • 8.1. Emulsifiable Concentrate
  • 8.2. Granule
  • 8.3. Suspension Concentrate
  • 8.4. Wettable Powder

9. Buprofezin Market, by Crop Type

  • 9.1. Cotton
  • 9.2. Fruit
    • 9.2.1. Berry
    • 9.2.2. Citrus
    • 9.2.3. Stone Fruit
  • 9.3. Paddy
  • 9.4. Vegetables
    • 9.4.1. Fruit Vegetables
    • 9.4.2. Leafy Vegetables
    • 9.4.3. Root Vegetables

10. Buprofezin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment

11. Buprofezin Market, by End User

  • 11.1. Large Scale Farms
  • 11.2. Small Scale Farms

12. Buprofezin Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Buprofezin Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Buprofezin Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Buprofezin Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Sumitomo Chemical Co., Ltd.
    • 16.3.2. Nippon Soda Co., Ltd.
    • 16.3.3. Jiangsu Changqing Agrochemical Co., Ltd.
    • 16.3.4. Adama Agricultural Solutions Ltd.
    • 16.3.5. UPL Limited
    • 16.3.6. Dhanuka Agritech Limited
    • 16.3.7. Nufarm Limited
    • 16.3.8. Jiangsu Huifeng Agrochemical Co., Ltd.
    • 16.3.9. Shandong United Pesticide Industry Co., Ltd.
    • 16.3.10. Gharda Chemicals Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BUPROFEZIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BUPROFEZIN MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 306. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 307. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 308. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 309. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 310. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 311. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 338. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 339. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 340. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 341. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 342. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 343. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 346. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 347. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 348. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 349. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 354. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 355. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 356. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 357. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 358. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 359. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 360. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 361. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 362. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 363. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 364. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 365. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 366. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 367. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 368. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 369. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 370. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 371. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 372. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 373. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 374. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)

TABLE 375